A phase II evaluation of lapatinib in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: A gynecologic oncology group study()

OBJECTIVE: Activation and dimerization of the ERBB family play a role in the pathogenesis and progression of ovarian cancer. We conducted a phase II trial to evaluate the activity and tolerability of lapatinib in patients with recurrent or persistent epithelial ovarian cancer (EOC) and to explore th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Garcia, Agustin A., Sill, Michael W., Lankes, Heather A., Godwin, Andrew K., Mannel, Robert S., Armstrong, Deborah K., Carolla, Robert L., Liepman, Marcia K., Spirtos, Nick M., Fischer, Edgar G., Leslie, Kimberly K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3971755/
https://ncbi.nlm.nih.gov/pubmed/22037316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2011.10.022
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados